A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy

Nature Biotechnology, Published online: 31 October 2022; doi:10.1038/s41587-022-01510-zIL-2 cytokine therapy is made safer by splitting a designed mimetic in two for tumor targeting…
Read More

About The Author

Jonathan Jeriah

See author's posts